Asia Pacific Theranostics Market Size, Share & Trends Analysis Report By End User, By Product (Radiopharmaceuticals, Diagnostic Imaging, IVD/Biomarker Screening, and Software & Services), By Application, By Country and Growth Forecast, 2023

List of Tables

The Asia Pacific Theranostics Market would witness market growth of 16.2% CAGR during the forecast period (2023-2030).

The China market dominated the Asia Pacific Theranostics Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $351.8 million by 2030. The Japan market is registering a CAGR of 15.6% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 17% during (2023 - 2030).

Imaging modalities such as functional MRI (fMRI), diffusion tensor imaging (DTI), and amyloid PET imaging enable visualization of brain structure, function, and pathology, aiding in diagnosing and monitoring neurodegenerative diseases. Biomarker-based assays, including cerebrospinal fluid (CSF) analysis and neuroimaging markers, provide diagnostic and prognostic information for neurologic conditions. Theranostic approaches help identify therapeutic targets and guide personalized treatment strategies for neurological disorders, facilitating early intervention and disease modification.

Theranostics are increasingly being explored for diagnosing and managing infectious diseases, including bacterial, viral, and fungal infections. Diagnostic techniques such as nucleic acid amplification tests (NAATs), serological assays, and imaging modalities enable rapid and accurate detection of infectious agents and assessment of disease severity. Theranostic approaches help identify antimicrobial resistance patterns, guide antibiotic stewardship initiatives, and optimize antimicrobial therapy for infectious diseases.

The expansion of healthcare expenditure in Australia enables greater access to advanced diagnostic and therapeutic technologies, including these, for patients nationwide. According to data released by the Australian government, the nation spent an estimated $241.3 billion, or almost $9,365 per person, on health-related products and services in 2021-2022. The total amount spent on recurrent and capital health care increased by 6.0% in real terms (adjusted for inflation) compared to 2020-21. Thus, the increasing expenditure in the healthcare sector and the growing elderly population drive the market's growth.

Based on End User, the market is segmented into Hospitals & Cancer Care Centers, Theranostics Centers, and Research & Academic Centers. Based on Product, the market is segmented into Radiopharmaceuticals, Diagnostic Imaging, IVD/Biomarker Screening, and Software & Services. Based on Application, the market is segmented into Prostate Cancer, Bone Metastasis, Other Cancers, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

Bayer AG
GE HealthCare Technologies, Inc.
Siemens Healthineers AG (Siemens AG)
Cardinal Health, Inc.
Canon, Inc.
Clarity Pharmaceuticals Ltd
Koninklijke Philips N.V.
Thermo Fisher Scientific, Inc.
Telix Pharmaceuticals Limited
ABX advanced biochemical compounds GmbH

Asia Pacific Theranostics Market Report Segmentation

By End User

Hospitals & Cancer Care Centers
Theranostics Centers
Research & Academic Centers

By Product

Radiopharmaceuticals
Diagnostic Imaging
IVD/Biomarker Screening
Software & Services

By Application

Prostate Cancer
Bone Metastasis
Other Cancers
Others

By Country

China
Japan
India
South Korea
Singapore
Malaysia
Rest of Asia Pacific

Chapter 1.Market Scope & Methodology

1.1Market Definition
1.2Objectives
1.3Market Scope
1.4Segmentation
- 1.4.1Asia Pacific Theranostics Market, by End User
- 1.4.2Asia Pacific Theranostics Market, by Product
- 1.4.3Asia Pacific Theranostics Market, by Application
- 1.4.4Asia Pacific Theranostics Market, by Country
1.5Methodology for the research

Chapter 2.Market at a Glance

2.1Key Highlights

Chapter 3.Market Overview

3.1Introduction
- 3.1.1Overview
  - 3.1.1.1Market Composition and Scenario
3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Restraints
- 3.2.3Market Opportunities
- 3.2.4Market Challenges
3.3Porter's Five Forces Analysis

Chapter 4.Asia Pacific Theranostics Market by End User

4.1Asia Pacific Hospitals & Cancer Care Centers Market by Country
4.2Asia Pacific Theranostics Centers Market by Country
4.3Asia Pacific Research & Academic Centers Market by Country

Chapter 5.Asia Pacific Theranostics Market by Product

5.1Asia Pacific Radiopharmaceuticals Market by Country
5.2Asia Pacific Diagnostic Imaging Market by Country
5.3Asia Pacific IVD/Biomarker Screening Market by Country
5.4Asia Pacific Software & Services Market by Country

Chapter 6.Asia Pacific Theranostics Market by Application

6.1Asia Pacific Prostate Cancer Market by Country
6.2Asia Pacific Bone Metastasis Market by Country
6.3Asia Pacific Other Cancers Market by Country
6.4Asia Pacific Others Market by Country

Chapter 7.Asia Pacific Theranostics Market by Country

7.1China Theranostics Market
- 7.1.1China Theranostics Market by End User
- 7.1.2China Theranostics Market by Product
- 7.1.3China Theranostics Market by Application
7.2Japan Theranostics Market
- 7.2.1Japan Theranostics Market by End User
- 7.2.2Japan Theranostics Market by Product
- 7.2.3Japan Theranostics Market by Application
7.3India Theranostics Market
- 7.3.1India Theranostics Market by End User
- 7.3.2India Theranostics Market by Product
- 7.3.3India Theranostics Market by Application
7.4South Korea Theranostics Market
- 7.4.1South Korea Theranostics Market by End User
- 7.4.2South Korea Theranostics Market by Product
- 7.4.3South Korea Theranostics Market by Application
7.5Singapore Theranostics Market
- 7.5.1Singapore Theranostics Market by End User
- 7.5.2Singapore Theranostics Market by Product
- 7.5.3Singapore Theranostics Market by Application
7.6Malaysia Theranostics Market
- 7.6.1Malaysia Theranostics Market by End User
- 7.6.2Malaysia Theranostics Market by Product
- 7.6.3Malaysia Theranostics Market by Application
7.7Rest of Asia Pacific Theranostics Market
- 7.7.1Rest of Asia Pacific Theranostics Market by End User
- 7.7.2Rest of Asia Pacific Theranostics Market by Product
- 7.7.3Rest of Asia Pacific Theranostics Market by Application

Chapter 8.Company Profiles

8.1Bayer AG
- 8.1.1Company Overview
- 8.1.2Financial Analysis
- 8.1.3Segmental and Regional Analysis
- 8.1.4Research & Development Expense
- 8.1.5Recent strategies and developments:
  - 8.1.5.1Acquisition and Mergers:
- 8.1.6SWOT Analysis
8.2GE HealthCare Technologies, Inc.
- 8.2.1Company Overview
- 8.2.2Financial Analysis
- 8.2.3Segmental and Regional Analysis
- 8.2.4Research & Development Expenses
- 8.2.5Recent strategies and developments:
  - 8.2.5.1Partnerships, Collaborations, and Agreements:
- 8.2.6SWOT Analysis
8.3Siemens Healthineers AG (Siemens AG)
- 8.3.1Company Overview
- 8.3.2Financial Analysis
- 8.3.3Segmental and Regional Analysis
- 8.3.4Research & Development Expense
- 8.3.5Recent strategies and developments:
  - 8.3.5.1Product Launches and Product Expansions:
- 8.3.6SWOT Analysis
8.4Cardinal Health, Inc.
- 8.4.1Company Overview
- 8.4.2Financial Analysis
- 8.4.3Segmental and Regional Analysis
- 8.4.4SWOT Analysis
8.5Canon, Inc.
- 8.5.1Company Overview
- 8.5.2Financial Analysis
- 8.5.3Segmental and Regional Analysis
- 8.5.4Research & Development Expenses
- 8.5.5SWOT Analysis
8.6Clarity Pharmaceuticals Ltd
- 8.6.1Company Overview
- 8.6.2Financial Analysis
- 8.6.3Research & Development Expenses
- 8.6.4SWOT Analysis
8.7Koninklijke Philips N.V.
- 8.7.1Company Overview
- 8.7.2Financial Analysis
- 8.7.3Segmental and Regional Analysis
- 8.7.4Research & Development Expense
- 8.7.5SWOT Analysis
8.8Thermo Fisher Scientific, Inc.
- 8.8.1Company Overview
- 8.8.2Financial Analysis
- 8.8.3Segmental and Regional Analysis
- 8.8.4Research & Development Expenses
- 8.8.5SWOT Analysis
8.9Telix Pharmaceuticals Limited
- 8.9.1Company Overview
- 8.9.2Financial Analysis
- 8.9.3Segmental and Regional Analysis
- 8.9.4Research & Development Expenses
- 8.9.5SWOT Analysis
8.10.ABX advanced biochemical compounds GmbH
- 8.10.1Company Overview
- 8.10.2SWOT Analysis

LIST OF TABLES

TABLE 1Asia Pacific Theranostics Market, 2019 - 2022, USD Million
TABLE 2Asia Pacific Theranostics Market, 2023 - 2030, USD Million
TABLE 3Asia Pacific Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 4Asia Pacific Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 5Asia Pacific Hospitals & Cancer Care Centers Market by Country, 2019 - 2022, USD Million
TABLE 6Asia Pacific Hospitals & Cancer Care Centers Market by Country, 2023 - 2030, USD Million
TABLE 7Asia Pacific Theranostics Centers Market by Country, 2019 - 2022, USD Million
TABLE 8Asia Pacific Theranostics Centers Market by Country, 2023 - 2030, USD Million
TABLE 9Asia Pacific Research & Academic Centers Market by Country, 2019 - 2022, USD Million
TABLE 10Asia Pacific Research & Academic Centers Market by Country, 2023 - 2030, USD Million
TABLE 11Asia Pacific Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 12Asia Pacific Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 13Asia Pacific Radiopharmaceuticals Market by Country, 2019 - 2022, USD Million
TABLE 14Asia Pacific Radiopharmaceuticals Market by Country, 2023 - 2030, USD Million
TABLE 15Asia Pacific Diagnostic Imaging Market by Country, 2019 - 2022, USD Million
TABLE 16Asia Pacific Diagnostic Imaging Market by Country, 2023 - 2030, USD Million
TABLE 17Asia Pacific IVD/Biomarker Screening Market by Country, 2019 - 2022, USD Million
TABLE 18Asia Pacific IVD/Biomarker Screening Market by Country, 2023 - 2030, USD Million
TABLE 19Asia Pacific Software & Services Market by Country, 2019 - 2022, USD Million
TABLE 20Asia Pacific Software & Services Market by Country, 2023 - 2030, USD Million
TABLE 21Asia Pacific Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 22Asia Pacific Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 23Asia Pacific Prostate Cancer Market by Country, 2019 - 2022, USD Million
TABLE 24Asia Pacific Prostate Cancer Market by Country, 2023 - 2030, USD Million
TABLE 25Asia Pacific Bone Metastasis Market by Country, 2019 - 2022, USD Million
TABLE 26Asia Pacific Bone Metastasis Market by Country, 2023 - 2030, USD Million
TABLE 27Asia Pacific Other Cancers Market by Country, 2019 - 2022, USD Million
TABLE 28Asia Pacific Other Cancers Market by Country, 2023 - 2030, USD Million
TABLE 29Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 30Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 31Asia Pacific Theranostics Market by Country, 2019 - 2022, USD Million
TABLE 32Asia Pacific Theranostics Market by Country, 2023 - 2030, USD Million
TABLE 33China Theranostics Market, 2019 - 2022, USD Million
TABLE 34China Theranostics Market, 2023 - 2030, USD Million
TABLE 35China Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 36China Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 37China Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 38China Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 39China Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 40China Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 41Japan Theranostics Market, 2019 - 2022, USD Million
TABLE 42Japan Theranostics Market, 2023 - 2030, USD Million
TABLE 43Japan Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 44Japan Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 45Japan Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 46Japan Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 47Japan Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 48Japan Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 49India Theranostics Market, 2019 - 2022, USD Million
TABLE 50India Theranostics Market, 2023 - 2030, USD Million
TABLE 51India Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 52India Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 53India Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 54India Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 55India Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 56India Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 57South Korea Theranostics Market, 2019 - 2022, USD Million
TABLE 58South Korea Theranostics Market, 2023 - 2030, USD Million
TABLE 59South Korea Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 60South Korea Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 61South Korea Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 62South Korea Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 63South Korea Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 64South Korea Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 65Singapore Theranostics Market, 2019 - 2022, USD Million
TABLE 66Singapore Theranostics Market, 2023 - 2030, USD Million
TABLE 67Singapore Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 68Singapore Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 69Singapore Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 70Singapore Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 71Singapore Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 72Singapore Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 73Malaysia Theranostics Market, 2019 - 2022, USD Million
TABLE 74Malaysia Theranostics Market, 2023 - 2030, USD Million
TABLE 75Malaysia Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 76Malaysia Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 77Malaysia Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 78Malaysia Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 79Malaysia Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 80Malaysia Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 81Rest of Asia Pacific Theranostics Market, 2019 - 2022, USD Million
TABLE 82Rest of Asia Pacific Theranostics Market, 2023 - 2030, USD Million
TABLE 83Rest of Asia Pacific Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 84Rest of Asia Pacific Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 85Rest of Asia Pacific Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 86Rest of Asia Pacific Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 87Rest of Asia Pacific Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 88Rest of Asia Pacific Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 89Key Information - Bayer AG
TABLE 90Key Information - GE HealthCare Technologies, Inc.
TABLE 91Key Information - Siemens Healthineers AG
TABLE 92key information - Cardinal Health, Inc.
TABLE 93Key Information - Canon, Inc.
TABLE 94Key Information - Clarity Pharmaceuticals Ltd
TABLE 95Key Information - Koninklijke Philips N.V.
TABLE 96Key Information - Thermo Fisher Scientific, Inc.
TABLE 97Key Information - Telix Pharmaceuticals Limited
TABLE 98Key Information - ABX advanced biochemical compounds GmbH

Asia Pacific Theranostics Market Size, Share & Trends Analysis Report By End User, By Product (Radiopharmaceuticals, Diagnostic Imaging, IVD/Biomarker Screening, and Software & Services), By Application, By Country and Growth Forecast, 2023 - 2030

Description

Table of Contents